Nanjing Dorra Pharmaceutical Technology Co., Ltd.

Dorra Pharma is a comprehensive pharmaceutical group integrating R&D, manufacturing, and sales. Our core business covers APIs and pharmaceutical intermediates, cosmetic ingredients, veterinary APIs, as well as finished formulations. We have established dual R&D centers in Nanjing and Taizhou, providing comprehensive capabilities from laboratory research to pilot-scale development. Our R&D centers are supported by nearly 100 full-time researchers and have successfully developed more than 300 compounds. We possess strong competitive advantages in key technologies including bromination, enzyme/metal catalysis, nitration, hydrogenation, and continuous flow chemistry, supported by multiple invention patents. Our manufacturing sites in Hubei and Jiangxi have been certified by major domestic and international regulatory authorities. Guided by our mission, “Creating more valuable product for the health of the life,” Dorra Pharma continuously pursues excellence and is committed to creating greater value for both customers and the company.